A citation-based method for searching scientific literature

Kumari Anuja, Amit Roy Chowdhury, Arka Saha, Souvick Roy, Arabinda Kumar Rath, Madhabananda Kar, Birendranath Banerjee. Int J Radiat Biol 2019
Times Cited: 12







List of co-cited articles
15 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Head and neck cancer stem cells.
S Krishnamurthy, J E Nör. J Dent Res 2012
59
8

Adenosine deaminases acting on RNA (ADARs): RNA-editing enzymes.
Liam P Keegan, Anne Leroy, Duncan Sproul, Mary A O'Connell. Genome Biol 2004
98
8

TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3.
B Wang, S-H Hsu, S Majumder, H Kutay, W Huang, S T Jacob, K Ghoshal. Oncogene 2010
284
8

Dynamic association of RNA-editing enzymes with the nucleolus.
Joana M P Desterro, Liam P Keegan, Miguel Lafarga, Maria Teresa Berciano, Mary O'Connell, Maria Carmo-Fonseca. J Cell Sci 2003
177
8

Oral cancer and precancerous lesions.
Brad W Neville, Terry A Day. CA Cancer J Clin 2002
683
8

Multilevel regulation of gene expression by microRNAs.
Eugene V Makeyev, Tom Maniatis. Science 2008
196
8

MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth.
Yael Nemlich, Eyal Greenberg, Rona Ortenberg, Michal J Besser, Iris Barshack, Jasmine Jacob-Hirsch, Elad Jacoby, Eran Eyal, Ludmila Rivkin, Victor G Prieto,[...]. J Clin Invest 2013
115
8

ADAR regulates RNA editing, transcript stability, and gene expression.
Isabel X Wang, Elizabeth So, James L Devlin, Yue Zhao, Ming Wu, Vivian G Cheung. Cell Rep 2013
110
8

The loop position of shRNAs and pre-miRNAs is critical for the accuracy of dicer processing in vivo.
Shuo Gu, Lan Jin, Yue Zhang, Yong Huang, Feijie Zhang, Paul N Valdmanis, Mark A Kay. Cell 2012
165
8

TGF-β Controls miR-181/ERK Regulatory Network during Retinal Axon Specification and Growth.
Sabrina Carrella, Sara Barbato, Ylenia D'Agostino, Francesco Giuseppe Salierno, Anna Manfredi, Sandro Banfi, Ivan Conte. PLoS One 2015
19
8

Human BLCAP transcript: new editing events in normal and cancerous tissues.
Federica Galeano, Anne Leroy, Claudia Rossetti, Irina Gromova, Philippe Gautier, Liam P Keegan, Luca Massimi, Concezio Di Rocco, Mary A O'Connell, Angela Gallo. Int J Cancer 2010
46
8

Role of microRNA in the pathogenesis of malignant lymphoma.
Hiroyuki Tagawa, Sho Ikeda, Kenichi Sawada. Cancer Sci 2013
42
8

Structural determinants of miRNAs for RISC loading and slicer-independent unwinding.
Tomoko Kawamata, Hervé Seitz, Yukihide Tomari. Nat Struct Mol Biol 2009
164
8

Mechanisms and implications of ADAR-mediated RNA editing in cancer.
Chen Wang, Jun Zou, Xiangyi Ma, Edward Wang, Guang Peng. Cancer Lett 2017
14
8

ADAR1-mediated regulation of melanoma invasion.
Yael Nemlich, Erez Nissim Baruch, Michal Judith Besser, Einav Shoshan, Menashe Bar-Eli, Liat Anafi, Iris Barshack, Jacob Schachter, Rona Ortenberg, Gal Markel. Nat Commun 2018
16
8

Cancer statistics in China, 2015.
Wanqing Chen, Rongshou Zheng, Peter D Baade, Siwei Zhang, Hongmei Zeng, Freddie Bray, Ahmedin Jemal, Xue Qin Yu, Jie He. CA Cancer J Clin 2016
8

Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells.
Cedric Gaggioli, Steven Hooper, Cristina Hidalgo-Carcedo, Robert Grosse, John F Marshall, Kevin Harrington, Erik Sahai. Nat Cell Biol 2007
909
8

Organ-wide profiling in mouse reveals high editing levels of Filamin B mRNA in the musculoskeletal system.
Philipp Czermak, Fabian Amman, Michael F Jantsch, Laura Cimatti. RNA Biol 2018
5
20

Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas.
Hatem O Kaseb, Helene Fohrer-Ting, Dale W Lewis, Eric Lagasse, Susanne M Gollin. Exp Cell Res 2016
18
8

MicroRNA: A novel target of curcumin in cancer therapy.
Hamed Mirzaei, Aria Masoudifar, Amirhossein Sahebkar, Naser Zare, Javid Sadri Nahand, Bahman Rashidi, Emadodin Mehrabian, Mohsen Mohammadi, Hamid Reza Mirzaei, Mahmoud Reza Jaafari. J Cell Physiol 2018
123
8



Hypoxia inducible factors in cancer stem cells.
J M Heddleston, Z Li, J D Lathia, S Bao, A B Hjelmeland, J N Rich. Br J Cancer 2010
294
8

Chemotherapy triggers HIF-1-dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype.
Haiquan Lu, Debangshu Samanta, Lisha Xiang, Huimin Zhang, Hongxia Hu, Ivan Chen, John W Bullen, Gregg L Semenza. Proc Natl Acad Sci U S A 2015
114
8


Hypoxia after liver surgery imposes an aggressive cancer stem cell phenotype on residual tumor cells.
Klaas M Govaert, Benjamin L Emmink, Maarten W Nijkamp, Zing J Cheung, Ernst J A Steller, Szabolcs Fatrai, Menno T de Bruijn, Onno Kranenburg, Inne H M Borel Rinkes. Ann Surg 2014
30
8

Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia.
Annamaria Rapisarda, Giovanni Melillo. Nat Rev Clin Oncol 2012
112
8

Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer.
Luciana P Schwab, Danielle L Peacock, Debeshi Majumdar, Jesse F Ingels, Laura C Jensen, Keisha D Smith, Richard C Cushing, Tiffany N Seagroves. Breast Cancer Res 2012
134
8

HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways.
Yuanyuan Yan, Fangxiao Liu, Li Han, Lin Zhao, Jianjun Chen, Olufunmilayo I Olopade, Miao He, Minjie Wei. J Exp Clin Cancer Res 2018
52
8

Antitumor effect of 2-methoxyestradiol in a rat orthotopic brain tumor model.
Seung-Hee Kang, Heidi T Cho, Sarojini Devi, Zhaobin Zhang, Daniel Escuin, Zhongxing Liang, Hui Mao, Daniel J Brat, Jeffrey J Olson, Jonathan W Simons,[...]. Cancer Res 2006
68
8

Hypoxic and Reoxygenated Microenvironment: Stemness and Differentiation State in Glioblastoma.
Mariana Maier Gaelzer, Mariana Silva Dos Santos, Bárbara Paranhos Coelho, Alice Hoffman de Quadros, Fabrício Simão, Vanina Usach, Fátima Costa Rodrigues Guma, Patrícia Setton-Avruj, Guido Lenz, Christianne G Salbego. Mol Neurobiol 2017
8
12

Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Preclinical Models of Colorectal Cancer.
Jennifer Haynes, Trevor D McKee, Andrew Haller, Yadong Wang, Cherry Leung, Deena M A Gendoo, Evelyne Lima-Fernandes, Antonija Kreso, Robin Wolman, Eva Szentgyorgyi,[...]. Clin Cancer Res 2018
8
12

Tumor hypoxia and malignant progression.
Peter Vaupel, Arnulf Mayer, Michael Höckel. Methods Enzymol 2004
296
8

Cancer stem cells in glioblastoma--molecular signaling and therapeutic targeting.
Zhi Huang, Lin Cheng, Olga A Guryanova, Qiulian Wu, Shideng Bao. Protein Cell 2010
141
8

Tissue transglutaminase as a central mediator in inflammation-induced progression of breast cancer.
Navneet Agnihotri, Santosh Kumar, Kapil Mehta. Breast Cancer Res 2013
50
8

CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells.
D Maciaczyk, D Picard, L Zhao, K Koch, D Herrera-Rios, G Li, V Marquardt, D Pauck, T Hoerbelt, W Zhang,[...]. Br J Cancer 2017
14
8


Regulation of miRNA Biogenesis and Histone Modification by K63-Polyubiquitinated DDX17 Controls Cancer Stem-like Features.
Shih-Han Kao, Wei-Chung Cheng, Yi-Ting Wang, Han-Tsang Wu, Han-Yu Yeh, Yu-Ju Chen, Ming-Hsui Tsai, Kou-Juey Wu. Cancer Res 2019
20
8

Hypoxic tumor microenvironment activates GLI2 via HIF-1α and TGF-β2 to promote chemoresistance in colorectal cancer.
Yen-An Tang, Yu-Feng Chen, Yi Bao, Sylvia Mahara, Siti Maryam J M Yatim, Gokce Oguz, Puay Leng Lee, Min Feng, Yu Cai, Ern Yu Tan,[...]. Proc Natl Acad Sci U S A 2018
80
8

Role of hypoxia-inducible factors (HIF) in the maintenance of stemness and malignancy of colorectal cancer.
Ramakrishna Vadde, Sarojamma Vemula, Rajeswari Jinka, Neha Merchant, Pallaval Veera Bramhachari, Ganji Purnachandra Nagaraju. Crit Rev Oncol Hematol 2017
40
8

The role of cancer stem cells in glioblastoma.
Swetha J Sundar, Jason K Hsieh, Sunil Manjila, Justin D Lathia, Andrew Sloan. Neurosurg Focus 2014
68
8

The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment.
Alexander Greenhough, Helena J M Smartt, Amy E Moore, Heather R Roberts, Ann C Williams, Christos Paraskeva, Abderrahmane Kaidi. Carcinogenesis 2009
805
8

The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness.
Bin Bao, Asfar S Azmi, Shadan Ali, Aamir Ahmad, Yiwei Li, Sanjeev Banerjee, Dejuan Kong, Fazlul H Sarkar. Biochim Biophys Acta 2012
116
8

MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation.
Kyung-Min Lee, Jennifer M Giltnane, Justin M Balko, Luis J Schwarz, Angel L Guerrero-Zotano, Katherine E Hutchinson, Mellissa J Nixon, Mónica V Estrada, Violeta Sánchez, Melinda E Sanders,[...]. Cell Metab 2017
177
8

Hypoxia-inducible factors, stem cells, and cancer.
Brian Keith, M Celeste Simon. Cell 2007
775
8

Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.
Zhizhong Li, Shideng Bao, Qiulian Wu, Hui Wang, Christine Eyler, Sith Sathornsumetee, Qing Shi, Yiting Cao, Justin Lathia, Roger E McLendon,[...]. Cancer Cell 2009
833
8

Fibroblast heterogeneity in the cancer wound.
Daniel Öhlund, Ela Elyada, David Tuveson. J Exp Med 2014
424
8


Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche.
Janine T Erler, Kevin L Bennewith, Thomas R Cox, Georgina Lang, Demelza Bird, Albert Koong, Quynh-Thu Le, Amato J Giaccia. Cancer Cell 2009
751
8



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.